Skip to main content
TipRanks
Go Ultimate75% OFF

Medeon Biodesign, Inc. (6499) Income Statement

Medeon Biodesign, Inc. Income Statement

Last quarter (Q2 2026), Medeon Biodesign, Inc.'s total revenue was NT$106.61M, a decrease of 3.42% from the same quarter last year. In Q2, Medeon Biodesign, Inc.'s net income was NT$-124.77M. See Medeon Biodesign, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 419.43MNT$ 292.81MNT$ 196.26MNT$ 298.32MNT$ 68.96M
NT$ 58.83MNT$ 83.41MNT$ -65.20MNT$ 186.81MNT$ 28.63M
NT$ 781.34MNT$ 955.62MNT$ 774.37MNT$ 674.65MNT$ 524.22M
Depreciation and AmortizationNT$ 107.36MNT$ 98.66MNT$ 95.67MNT$ 63.80MNT$ 59.02M
NT$ -615.15MNT$ -754.42MNT$ -1.14BNT$ -370.10MNT$ -453.87M
NT$ -722.51MNT$ -872.20MNT$ -838.99MNT$ -487.84MNT$ -512.88M
NT$ 2.82MNT$ 26.97MNT$ -391.70MNT$ 48.72MNT$ -20.69M
NT$ -719.69MNT$ -858.64MNT$ -1.24BNT$ -439.12MNT$ -513.91M
NT$ -668.06MNT$ -805.51MNT$ -1.20BNT$ -433.76MNT$ 2.08B
Per Share Metrics
Basic EPSNT$ -7.24NT$ -8.74NT$ -13.09NT$ -4.71NT$ 22.65
Diluted EPSNT$ -7.24NT$ -8.74NT$ -13.09NT$ -4.71NT$ 22.57
Weighted Average Shares Outstanding92.27M92.19M92.03M92.02M91.75M
Weighted Average Shares Outstanding (Diluted)92.27M92.19M92.03M92.02M92.08M

Currency in TWD

Medeon Biodesign, Inc. Earnings and Revenue History

-1.5B01.5B3B-2000 %0 %2000 %4000 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin